ICU Medical Current Ratio 2006-2018 | ICUI

ICU Medical current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ICU Medical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.93B $0.25B 3.72
2018-09-30 $0.91B $0.20B 4.51
2018-06-30 $0.90B $0.20B 4.44
2018-03-31 $0.87B $0.20B 4.37
2017-12-31 $0.87B $0.21B 4.11
2017-09-30 $0.91B $0.20B 4.65
2017-06-30 $0.90B $0.19B 4.78
2017-03-31 $0.89B $0.16B 5.52
2016-12-31 $0.57B $0.04B 14.04
2016-09-30 $0.50B $0.03B 15.47
2016-06-30 $0.54B $0.04B 13.18
2016-03-31 $0.52B $0.03B 15.16
2015-12-31 $0.51B $0.04B 11.85
2015-09-30 $0.51B $0.04B 13.81
2015-06-30 $0.47B $0.03B 16.43
2015-03-31 $0.45B $0.03B 13.80
2014-12-31 $0.43B $0.03B 15.06
2014-09-30 $0.43B $0.03B 14.51
2014-06-30 $0.41B $0.03B 15.21
2014-03-31 $0.40B $0.03B 15.71
2013-12-31 $0.39B $0.03B 14.67
2013-09-30 $0.36B $0.03B 13.44
2013-06-30 $0.35B $0.03B 12.35
2013-03-31 $0.33B $0.03B 13.07
2012-12-31 $0.33B $0.03B 11.18
2012-09-30 $0.31B $0.03B 10.81
2012-06-30 $0.29B $0.03B 9.84
2012-03-31 $0.28B $0.03B 10.87
2011-12-31 $0.26B $0.03B 8.89
2011-09-30 $0.24B $0.02B 9.85
2011-06-30 $0.24B $0.03B 8.92
2011-03-31 $0.22B $0.03B 8.07
2010-12-31 $0.21B $0.03B 7.97
2010-09-30 $0.20B $0.03B 7.34
2010-06-30 $0.18B $0.03B 5.88
2010-03-31 $0.18B $0.03B 5.86
2009-12-31 $0.21B $0.03B 6.17
2009-09-30 $0.21B $0.02B 8.96
2009-06-30 $0.21B $0.02B 9.91
2009-03-31 $0.19B $0.02B 8.36
2008-12-31 $0.18B $0.02B 8.17
2008-09-30 $0.18B $0.02B 8.10
2008-06-30 $0.17B $0.02B 7.95
2008-03-31 $0.16B $0.02B 7.74
2007-12-31 $0.15B $0.02B 7.14
2007-09-30 $0.16B $0.02B 7.92
2007-06-30 $0.17B $0.02B 8.57
2007-03-31 $0.17B $0.02B 10.81
2006-12-31 $0.17B $0.02B 10.77
2006-09-30 $0.17B $0.02B 9.45
2006-06-30 $0.16B $0.02B 9.49
2006-03-31 $0.15B $0.01B 10.23
2005-12-31 $0.14B $0.01B 9.92
2005-09-30 $0.13B $0.01B 8.85
2005-06-30 $0.12B $0.01B 8.39
2005-03-31 $0.13B $0.01B 14.16
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.899B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14